US6605712B1
(en)
*
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
US5610042A
(en)
*
|
1991-10-07 |
1997-03-11 |
Ciba-Geigy Corporation |
Methods for stable transformation of wheat
|
US7285416B2
(en)
|
2000-01-24 |
2007-10-23 |
Gendaq Limited |
Regulated gene expression in plants
|
US7262055B2
(en)
|
1998-08-25 |
2007-08-28 |
Gendaq Limited |
Regulated gene expression in plants
|
US5631152A
(en)
*
|
1994-10-26 |
1997-05-20 |
Monsanto Company |
Rapid and efficient regeneration of transgenic plants
|
CN1208437A
(zh)
|
1996-06-21 |
1999-02-17 |
孟山都公司 |
农杆菌介导转化法生产稳定转化的可育小麦的方法及其相关组分
|
US5773269A
(en)
*
|
1996-07-26 |
1998-06-30 |
Regents Of The University Of Minnesota |
Fertile transgenic oat plants
|
US6002068A
(en)
*
|
1996-12-19 |
1999-12-14 |
Novartis Finance Corporation |
Methods for conferring insect resistance to a monocot using a perioxidase coding sequence
|
US6872871B2
(en)
*
|
1998-02-02 |
2005-03-29 |
Odyssey Thera Inc. |
Mapping molecular interactions in plants with protein fragments complementation assays
|
US7102056B1
(en)
|
1997-04-29 |
2006-09-05 |
The Regents Of The University Of California |
Compositions and methods for plant transformation and regeneration
|
US6235529B1
(en)
|
1997-04-29 |
2001-05-22 |
The Regents Of The University Of California |
Compositions and methods for plant transformation and regeneration
|
MX257801B
(en)
|
1997-06-02 |
2008-06-10 |
Syngenta Participations Ag |
Plant transformation methods
|
US6486384B1
(en)
|
1997-09-24 |
2002-11-26 |
The Regents Of The University Of California |
Methods and compositions for transformation of cereals using cultured shoot meristematic tissue
|
WO1999016890A2
(en)
|
1997-09-30 |
1999-04-08 |
The Regents Of The University Of California |
Production of proteins in plant seeds
|
US6060315A
(en)
*
|
1997-12-01 |
2000-05-09 |
Lockheed Martin Energy Research Corporation |
Method for facilitating the introduction of material into cells
|
US6153811A
(en)
|
1997-12-22 |
2000-11-28 |
Dekalb Genetics Corporation |
Method for reduction of transgene copy number
|
PT1054985E
(pt)
|
1998-02-20 |
2012-07-03 |
Syngenta Ltd |
Produção de semente híbrida
|
US5973227A
(en)
*
|
1998-05-06 |
1999-10-26 |
University Of Saskatchewan |
Flax transformation
|
US7897843B2
(en)
|
1999-03-23 |
2011-03-01 |
Mendel Biotechnology, Inc. |
Transcriptional regulation of plant biomass and abiotic stress tolerance
|
US20050086718A1
(en)
|
1999-03-23 |
2005-04-21 |
Mendel Biotechnology, Inc. |
Plant transcriptional regulators of abiotic stress
|
WO2001033944A1
(en)
|
1999-11-10 |
2001-05-17 |
University Of Washington |
Compositions and methods for modulation of plant cell division
|
EP1950306A1
(de)
|
1999-11-17 |
2008-07-30 |
Mendel Biotechnology, Inc. |
Umweltstress-Toleranzgene
|
BR0015634A
(pt)
|
1999-11-17 |
2002-12-31 |
Mendel Biotechnology Inc |
Planta, polinucleotìdeo, vetor, célula, composição, polipeptìdeo, métodos para produzir uma planta e para identificar um fator que é modulado por, ou interage com, um polipeptìdeo codificado por um polinucleotìdeo, uma molécula que module a atividade ou a expressão de um polinucleotìdeo ou polipeptìdeo de interesse e uma sequência similar ou homóloga a um ou mais polinucleotìdeos e sistema integrado, meio computadorizado ou legìvel em computador
|
US6812028B1
(en)
*
|
1999-12-10 |
2004-11-02 |
University Of Guelph |
Embryogenesis and plant regeneration from microspores
|
US6750379B2
(en)
|
2000-03-09 |
2004-06-15 |
Dekalb Genetics Corporation |
Homologous recombination-mediated transgene alterations in plants
|
US6580019B1
(en)
|
2000-03-09 |
2003-06-17 |
Dekalb Genetics Corporation |
Non-reciprocal recombination-mediated transgene deletion in transgenic plants
|
US6806399B1
(en)
*
|
2000-04-19 |
2004-10-19 |
Carmel-Haifa University Economic Corporation Ltd. |
Pollen-mediated method for transformation of maize, tomato or melon
|
US7468475B2
(en)
|
2000-06-16 |
2008-12-23 |
Schmuelling Thomas |
Method for modifying plant morphology, biochemistry and physiology
|
US6995016B2
(en)
|
2000-08-17 |
2006-02-07 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food |
Process for inducing direct somatic embryogenesis in immature scutella cells of pooideae, and rapidly regenerating fertile plants
|
WO2002015675A1
(en)
|
2000-08-22 |
2002-02-28 |
Mendel Biotechnology, Inc. |
Genes for modifying plant traits iv
|
FR2815969B1
(fr)
|
2000-10-30 |
2004-12-10 |
Aventis Cropscience Sa |
Plantes tolerantes aux herbicides par contournement de voie metabolique
|
WO2002070672A2
(en)
|
2001-03-06 |
2002-09-12 |
The Dow Chemical Company |
Plant cell having animal-type sugar chain adding function
|
US7326549B2
(en)
|
2001-03-19 |
2008-02-05 |
Cargill, Incorporated |
Myo-inositol oxygenases
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
WO2002080849A2
(en)
*
|
2001-04-06 |
2002-10-17 |
University Of Chicago |
Chemotherapeutic induction of egr-1 promoter activity
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
US7452705B2
(en)
|
2001-05-22 |
2008-11-18 |
The University Of Chicago |
N4 virion single-stranded DNA dependent RNA polymerase
|
MXPA03010967A
(es)
|
2001-05-30 |
2004-10-28 |
Chromos Molecular Systems Inc |
Cromosomas artificiales de plantas, usos de los mismos y metodos para preparar cromosomas artificiales de plantas.
|
WO2003038112A2
(en)
|
2001-10-26 |
2003-05-08 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
AR037778A1
(es)
|
2001-12-11 |
2004-12-01 |
Advisys Inc |
Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos
|
US20040014956A1
(en)
|
2002-02-01 |
2004-01-22 |
Sequitur, Inc. |
Double-stranded oligonucleotides
|
US20060009409A1
(en)
*
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
EP1572902B1
(de)
*
|
2002-02-01 |
2014-06-11 |
Life Technologies Corporation |
HOCHWIRKSAME siRNAS ZUR REDUZIERUNG DER EXPRESSION VON ZIELGENEN
|
BR0311324A
(pt)
|
2002-05-22 |
2005-06-28 |
Monsanto Technology Llc |
Dessaturases de ácidos graxos de fungos
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
US7667099B2
(en)
|
2002-06-20 |
2010-02-23 |
Board Of Trustees Of Michigan State University |
Plastid division and related genes and proteins, and methods of use
|
CA2501188C
(en)
|
2002-07-15 |
2012-05-15 |
Board Of Regents, The University Of Texas System |
Combinatorial protein library screening by periplasmic expression
|
GB0217033D0
(en)
|
2002-07-23 |
2002-08-28 |
Delta Biotechnology Ltd |
Gene and polypeptide sequences
|
US20040029275A1
(en)
*
|
2002-08-10 |
2004-02-12 |
David Brown |
Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
|
EP2269618A1
(de)
|
2002-08-12 |
2011-01-05 |
Jennerex Biotherapeutics ULC |
Ein onkolytisches Vaccinia-Virus zur Verwendung in Kombination mit Chemotherapie zur Behandlung von Krebs
|
WO2004022707A2
(en)
*
|
2002-09-03 |
2004-03-18 |
The Regents Of The University Of California |
Method and compositions for transformation and regeneration of maize
|
EP2272962B1
(de)
|
2002-09-18 |
2017-01-18 |
Mendel Biotechnology, Inc. |
Polynukleotide und Polypeptide in Pflanzen
|
WO2004073641A2
(en)
|
2003-02-18 |
2004-09-02 |
Kevin Slawin |
Induced activation in dendritic cells
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
US7655833B2
(en)
|
2003-05-29 |
2010-02-02 |
Brookhaven Science Associates, Llc |
ADS genes for reducing saturated fatty acid levels in seed oils
|
WO2005001098A1
(en)
|
2003-06-30 |
2005-01-06 |
Commonwealth Scientific And Industrial Research Organisation |
Wheat with altered branching enzyme activity and starch and starch containing products derived thereform
|
WO2006023869A2
(en)
|
2004-08-24 |
2006-03-02 |
Monsanto Technology Llc |
Adenylate translocator protein gene non-coding regulatory elements for use in plants
|
CA2584960A1
(en)
|
2004-10-21 |
2006-05-04 |
Charles L. Niblett |
Methods and materials for conferring resistance to pests and pathogens of plants
|
DK2302055T3
(da)
|
2004-11-12 |
2014-10-13 |
Asuragen Inc |
Fremgangsmåder og sammensætninger involverende miRNA og miRNA-inhibitormolekyler
|
CN100362104C
(zh)
|
2004-12-21 |
2008-01-16 |
华中农业大学 |
利用水稻转录因子基因OsNACx提高植物抗旱耐盐能力
|
AR053269A1
(es)
|
2005-05-16 |
2007-04-25 |
Monsanto Technology Llc |
Plantas y semillas de maiz con mejoramiento de asparagina y proteina
|
WO2006125065A2
(en)
|
2005-05-18 |
2006-11-23 |
The Board Of Trustees Operating Michigan State University |
Resistance to soybean aphid in early maturing soybean germplasm
|
BRPI0614695A2
(pt)
|
2005-07-29 |
2011-04-12 |
Targeted Growth Inc |
proteção de proteìna krp mutante negativa dominante de inibição de complexo ciclina-cdk ativo por krp do tipo silvestre
|
KR20090004839A
(ko)
*
|
2005-09-07 |
2009-01-12 |
제네렉스, 인코포레이티드 |
Gm-csf를 발현하는 폭스바이러스를 사용한 전이성및/또는 전신 파종성 암의 전신 치료법
|
WO2007030674A2
(en)
*
|
2005-09-07 |
2007-03-15 |
Maxcyte, Inc. |
Use of nucleases to improve viability and enhance transgene expression in transfected cells
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
CN101374408A
(zh)
|
2005-12-15 |
2009-02-25 |
目标栽培公司 |
通过在早期胚胎发育期间生长和/或发育相关基因的转基因过量表达来增加种子大小和种子数目
|
US7663020B2
(en)
*
|
2006-01-11 |
2010-02-16 |
Agrinomics Llc |
Generation of plants with altered oil content
|
EP2368569A3
(de)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Zusammensetzungen und Verfahren im Zusammenhang mit Proteinen des Staphylococcus-Bakteriums
|
US7868228B2
(en)
|
2006-01-31 |
2011-01-11 |
Monsanto Technology Llc |
Phosphopantetheinyl transferases from bacteria
|
US7820883B2
(en)
*
|
2006-03-15 |
2010-10-26 |
Dow Agrosciences Llc |
Resistance to auxinic herbicides
|
US8304239B2
(en)
|
2006-03-31 |
2012-11-06 |
Reliance Life Sciences Pvt Ltd. |
Direct regeneration of plantlets in Jatropha curcas
|
US7977535B2
(en)
|
2006-07-12 |
2011-07-12 |
Board Of Trustees Of Michigan State University |
DNA encoding ring zinc-finger protein and the use of the DNA in vectors and bacteria and in plants
|
EP2069791B1
(de)
|
2006-07-27 |
2012-01-25 |
University of Maryland, Baltimore |
Zellulärer rezeptor für antiproliferativen faktor
|
EP2839837B1
(de)
|
2006-09-15 |
2019-05-08 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Onkolytisches farmington rhabdovirus
|
EP2121935B1
(de)
|
2006-09-25 |
2011-07-13 |
Freie Universität Berlin |
Transkriptionsrepressoren der cytokin-signalgebung und deren verwendung
|
CA3058450A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
US8753840B2
(en)
*
|
2006-10-20 |
2014-06-17 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Modified cyanobacteria
|
CA2669676C
(en)
*
|
2006-11-15 |
2018-01-23 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
CA2669989A1
(en)
|
2006-11-15 |
2008-05-22 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
US8106253B2
(en)
*
|
2006-11-15 |
2012-01-31 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
CA2669920C
(en)
|
2006-11-15 |
2016-05-10 |
Agrigenetics, Inc. |
Generation of plants expressing an imq polypeptide and having altered protein, fiber or oil content
|
CA2669875C
(en)
|
2006-11-15 |
2017-01-03 |
Agrigenetics, Inc. |
Generation of plants with altered protein, fiber, or oil content
|
CA2671264C
(en)
|
2006-11-30 |
2015-11-24 |
Research Development Foundation |
Improved immunoglobulin libraries
|
BRPI0721171A2
(pt)
*
|
2006-12-15 |
2014-03-18 |
Agrinomics Llc |
Produção de plantas com conteúdo alterado de óleos, proteínas ou fibras
|
BRPI0720303A2
(pt)
*
|
2006-12-15 |
2014-12-23 |
Agrinomics Llc |
Produção de plantas com conteúdo de óleos, proteínas ou fibras
|
BRPI0720759A2
(pt)
*
|
2006-12-15 |
2014-01-21 |
Agrinomics Llc |
Produção de plantas com conteúdo alterado de óleos, proteínas ou fibras
|
BRPI0720302A2
(pt)
*
|
2006-12-15 |
2014-02-04 |
Agrinomics Llc |
Produção de plantas com conteúdo alterado de óleos, proteínas ou fibras
|
CA2965042A1
(en)
|
2006-12-15 |
2008-06-26 |
Agrigenetics, Inc. |
Generation of plants with altered oil, protein, or fiber content
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
AU2008247819B2
(en)
|
2007-05-01 |
2013-02-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
WO2008157559A2
(en)
*
|
2007-06-18 |
2008-12-24 |
Agrinomics Llc |
Generation of plants with altered oil, protein or fiber content
|
CN101951948B
(zh)
|
2007-08-31 |
2015-12-09 |
芝加哥大学 |
与针对葡萄球菌性肺部疾病和病症进行免疫相关的方法和组合物
|
EP2944649A1
(de)
|
2008-01-10 |
2015-11-18 |
Research Development Foundation |
Impfstoffe und diagnostika für ehrlichiosen
|
BRPI0907637A8
(pt)
|
2008-01-25 |
2018-01-02 |
P53 Inc |
biomarcadores p53
|
KR101871192B1
(ko)
|
2008-06-04 |
2018-06-27 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
비-바이러스 접근법을 사용한 iPS 세포의 생산 방법
|
CN107988261A
(zh)
|
2008-08-12 |
2018-05-04 |
细胞动力国际有限公司 |
产生ips细胞的方法
|
EP2328603A4
(de)
|
2008-08-18 |
2013-01-02 |
Univ Maryland |
Apf-derivate und verwendungsverfahren
|
ES2840750T3
(es)
*
|
2008-09-22 |
2021-07-07 |
Baylor College Medicine |
Métodos y composiciones para generar una respuesta inmune induciendo CD40 y adaptadores del receptor de reconocimiento de patrones
|
BRPI0920041A2
(pt)
|
2008-10-06 |
2017-06-27 |
Univ Chicago |
composições e processos relacionados às proteínas eap, emp e/ou adsa bacterianas
|
CA2737595C
(en)
|
2008-10-14 |
2017-09-12 |
Monsanto Technology Llc |
Utilization of fatty acid desaturases from hemiselmis spp.
|
US9133475B2
(en)
|
2008-11-26 |
2015-09-15 |
Board Of Trustees Of Michigan State University |
Aphid resistant soybean plants
|
US9084781B2
(en)
|
2008-12-10 |
2015-07-21 |
Novartis Ag |
MEK mutations conferring resistance to MEK inhibitors
|
US8362318B2
(en)
|
2008-12-18 |
2013-01-29 |
Board Of Trustees Of Michigan State University |
Enzyme directed oil biosynthesis in microalgae
|
WO2010084488A1
(en)
|
2009-01-20 |
2010-07-29 |
Ramot At Tel-Aviv University Ltd. |
Mir-21 promoter driven targeted cancer therapy
|
WO2010096510A2
(en)
|
2009-02-17 |
2010-08-26 |
Edenspace Systems Corporation |
Tempering of cellulosic biomass
|
EP3281947B1
(de)
|
2009-04-03 |
2020-02-12 |
The University of Chicago |
Zusammensetzungen und verfahren in verbindung mit protein-a (spa)-varianten
|
EP2424885B1
(de)
|
2009-04-28 |
2016-03-23 |
Vanderbilt University |
Zusammensetzungen und verfahren zur behandlung von erkrankungen im zusammenhang mit epithelzellapoptose
|
WO2010138971A1
(en)
|
2009-05-29 |
2010-12-02 |
Edenspace Systems Corporation |
Plant gene regulatory elements
|
KR101811235B1
(ko)
|
2009-06-05 |
2017-12-21 |
셀룰러 다이내믹스 인터내셔널, 인코포레이티드 |
T 세포 및 조혈 세포의 재프로그래밍
|
US20110053803A1
(en)
|
2009-08-26 |
2011-03-03 |
Xin Ge |
Methods for creating antibody libraries
|
BR112012005774B8
(pt)
|
2009-09-14 |
2023-02-14 |
Jennerex Inc |
uso de um inibidor de quinase antiangiogênico no tratamento de câncer
|
WO2011050271A1
(en)
|
2009-10-23 |
2011-04-28 |
Monsanto Technology Llc |
Methods and compositions for expression of transgenes in plants
|
MX337062B
(es)
|
2009-12-10 |
2016-02-11 |
Ottawa Hospital Res Inst |
Rabdovirus oncolítico.
|
WO2011082253A2
(en)
|
2009-12-30 |
2011-07-07 |
Board Of Trustees Of Michigan State University |
A method to produce acetyldiacylglycerols (ac-tags) by expression ofan acetyltransferase gene isolated from euonymus alatus (burning bush)
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
EP3028699B1
(de)
|
2010-02-25 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Braf-mutationen für resistenz gegen braf-inhibitoren
|
EP2542678B1
(de)
|
2010-03-04 |
2017-04-12 |
InteRNA Technologies B.V. |
Mirna-molekül, das durch seine quelle definiert ist, und seine therapeutischen verwendungen bei emt assoziierten krebs
|
US8808699B2
(en)
|
2010-04-05 |
2014-08-19 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
|
WO2011126976A1
(en)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
DK2560672T3
(en)
|
2010-04-19 |
2014-03-17 |
Res Dev Foundation |
RTEF-1 variants and their uses
|
AU2011255481B2
(en)
|
2010-05-19 |
2014-09-11 |
The Samuel Roberts Noble Foundation, Inc. |
Altered leaf morphology and enhanced agronomic properties in plants
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
EP3889254B1
(de)
|
2010-06-09 |
2024-08-14 |
Dana-Farber Cancer Institute, Inc. |
Mek1-mutation für resistenz gegenüber raf- und mek-inhibitoren
|
KR101861168B1
(ko)
|
2010-06-15 |
2018-05-31 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
작은 부피의 말초 혈액으로부터의 유도된 만능 줄기 세포의 생성
|
CA2802087A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
SG186290A1
(en)
|
2010-07-02 |
2013-01-30 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
NZ704322A
(en)
|
2010-07-06 |
2016-07-29 |
Interna Technologies Bv |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
|
JP5897002B2
(ja)
|
2010-07-07 |
2016-04-13 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
プログラミングによる内皮細胞の産生
|
WO2012018933A2
(en)
|
2010-08-04 |
2012-02-09 |
Cellular Dynamics International, Inc. |
Reprogramming immortalized b cells
|
EP2614074A1
(de)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Verfahren und zusammensetzungen mit schützenden staphylokokken-antigenen
|
CN105457016B
(zh)
|
2010-09-22 |
2022-06-24 |
科罗拉多大学董事会 |
Smad7的治疗应用
|
WO2012061615A1
(en)
|
2010-11-03 |
2012-05-10 |
The Samuel Roberts Noble Foundation, Inc. |
Transcription factors for modification of lignin content in plants
|
CN103429258B
(zh)
|
2011-01-04 |
2016-03-09 |
新罗杰公司 |
通过施用溶瘤痘苗病毒生成针对肿瘤抗原的抗体和生成肿瘤特异性补体依赖性细胞毒性
|
EP2474617A1
(de)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR zur Behandlung von Neoangiogenese
|
CA2826467C
(en)
|
2011-02-07 |
2019-11-12 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
EP2673358B1
(de)
|
2011-02-08 |
2019-01-09 |
FUJIFILM Cellular Dynamics, Inc. |
Herstellung blutbildender vorläuferzellen durch programmierung
|
EP2694534B1
(de)
|
2011-04-08 |
2018-06-20 |
Evaxion Biotech ApS |
Proteine und nukleinsäuren zur verwendung für impstoffe gegen staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
US8901371B2
(en)
|
2011-05-06 |
2014-12-02 |
The Samuel Roberts Noble Foundation, Inc. |
Compositions and methods for improved plant feedstock
|
US9920327B2
(en)
|
2011-06-02 |
2018-03-20 |
The Regents Of The University Of California |
Plants with elevated levels of glucan
|
CA2872045A1
(en)
|
2011-06-08 |
2012-12-13 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
WO2013005211A2
(en)
|
2011-07-05 |
2013-01-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Boron complexing plant materials and uses thereof cross-reference to related applications
|
US20130040302A1
(en)
|
2011-07-11 |
2013-02-14 |
Thomas J. Burke |
Methods for cell reprogramming and genome engineering
|
EP2744517B1
(de)
|
2011-08-15 |
2019-03-13 |
The University of Chicago |
Zusammensetzungen und verfahren in zusammenhang mit antikörpern gegen das staphylokokken-protein a
|
US20130101664A1
(en)
|
2011-08-18 |
2013-04-25 |
Donald W. Kufe |
Muc1 ligand traps for use in treating cancers
|
WO2013053899A1
(en)
|
2011-10-12 |
2013-04-18 |
Moeller Niels Iversen |
Peptides derived from campylobacter jejuni and their use in vaccination
|
ES2886147T3
(es)
|
2011-12-22 |
2021-12-16 |
Interna Tech B V |
MiARN para el tratamiento del cáncer de cabeza y de cuello
|
US9968668B2
(en)
|
2012-04-26 |
2018-05-15 |
The University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
CN104703622B
(zh)
|
2012-04-26 |
2017-05-24 |
芝加哥大学 |
与金黄色葡萄球菌疾病期间抵消凝固酶活性的抗体相关的组合物和方法
|
WO2014022455A1
(en)
|
2012-07-31 |
2014-02-06 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for in vivo induction of pancreatic beta cell formation
|
AU2013317586B2
(en)
|
2012-09-24 |
2017-12-07 |
Seminis Vegetable Seeds, Inc. |
Methods and compositions for extending shelf life of plant products
|
EP2912058A1
(de)
|
2012-10-23 |
2015-09-02 |
The Board of Regents of The University of Texas System |
Antikörper mit manipulierten igg-fc-domänen
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
CA2836403A1
(en)
|
2013-01-04 |
2014-07-04 |
Board Of Trustees Of Michigan State University |
New sources of aphid resistance in soybean plants
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
CA2901501C
(en)
|
2013-02-21 |
2023-03-07 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Vaccine composition
|
WO2014130770A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US10086093B2
(en)
|
2013-02-28 |
2018-10-02 |
The General Hospital Corporation |
miRNA profiling compositions and methods of use
|
US20160010094A1
(en)
|
2013-03-01 |
2016-01-14 |
University Of Pretoria |
Transgenic cell selection
|
US10456448B2
(en)
|
2013-03-08 |
2019-10-29 |
The Regents Of The University Of Colorado, A Body Corporate |
PTD-SMAD7 therapeutics
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
JP6541639B2
(ja)
|
2013-03-14 |
2019-07-10 |
ベリカム ファーマシューティカルズ, インコーポレイテッド |
T細胞増殖をコントロールするための方法
|
WO2014197638A2
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
JP2016531147A
(ja)
|
2013-09-09 |
2016-10-06 |
フィジーン、エルエルシーFigene, Llc |
コンドロサイトまたは軟骨型細胞の再生のための遺伝子治療
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
WO2015070050A1
(en)
|
2013-11-08 |
2015-05-14 |
Baylor Research Institute |
Nuclear loclization of glp-1 stimulates myocardial regeneration and reverses heart failure
|
EP4227685A3
(de)
|
2013-12-03 |
2024-02-28 |
Evaxion Biotech A/S |
Proteine und nukleinsäuren für impfstoffe gegen staphylococcus aureus
|
US10392629B2
(en)
|
2014-01-17 |
2019-08-27 |
Board Of Trustees Of Michigan State University |
Increased caloric and nutritional content of plant biomass
|
EP3099719B1
(de)
|
2014-01-29 |
2020-04-01 |
Dana-Farber Cancer Institute, Inc. |
Antikörper gegen die muc1-c/extrazelluläre domäne (/muc1-c/ecd)
|
EP3104866A4
(de)
|
2014-02-14 |
2017-08-02 |
Bellicum Pharmaceuticals, Inc. |
Verfahren zur aktivierung von t-zellen mit einem induzierbaren chimären polypeptid
|
US10214741B2
(en)
|
2014-02-14 |
2019-02-26 |
University Of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
EP3110836A1
(de)
|
2014-02-25 |
2017-01-04 |
Research Development Foundation |
Sty-peptide zur hemmung von angiogenese
|
BR112016020670B1
(pt)
|
2014-03-07 |
2023-02-07 |
E.I. Du Pont De Nemours And Company |
Método de extração de um embrião, sistema para a extração de um embrião
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
WO2015193653A1
(en)
|
2014-06-16 |
2015-12-23 |
Consejo Nacional De Investigaciones Cientificas Y Tecnicas |
Oxidative resistance chimeric genes and proteins, and transgenic plants including the same
|
WO2016036746A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
EP3191594A4
(de)
|
2014-09-11 |
2018-06-13 |
Marrone Bio Innovations, Inc. |
Genom des chromobacterium subtsugae
|
EP3215522B1
(de)
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
Gegen bob1 gerichtete t-zell-rezeptoren und verwendungen davon
|
AU2015346281B2
(en)
|
2014-11-12 |
2021-12-02 |
Nmc, Inc. |
Transgenic plants with engineered redox sensitive modulation of photosynthetic antenna complex pigments and methods for making the same
|
EP3218002B1
(de)
|
2014-11-13 |
2020-08-19 |
Evaxion Biotech ApS |
Aus acinetobacter baumannii abgeleitete peptide und deren verwendung bei der impfung
|
US20160175359A1
(en)
|
2014-12-15 |
2016-06-23 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
EP3244918A2
(de)
|
2015-01-12 |
2017-11-22 |
Evaxion Biotech ApS |
Proteine und nukleinsäuren zur verwendung für impfstoffe gegen klebsiella pneumoniae
|
US20180002656A1
(en)
|
2015-01-28 |
2018-01-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
EP3256490A1
(de)
|
2015-02-09 |
2017-12-20 |
Research Development Foundation |
Manipulierte immunglobulin-fc-polypeptide mit verbesserter komplementaktivierung
|
EP3259346B1
(de)
|
2015-02-20 |
2024-08-07 |
Baylor College of Medicine |
P63-inaktivierung zur behandlung von herzinsuffizienz
|
US20160263155A1
(en)
|
2015-03-10 |
2016-09-15 |
Leiden University Medical Center |
T cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof
|
WO2017005670A1
(en)
|
2015-07-04 |
2017-01-12 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting pseudomonas aeruginosa
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
WO2017070333A1
(en)
|
2015-10-20 |
2017-04-27 |
Cellular Dynamics International, Inc. |
Multi-lineage hematopoietic precursor cell production by genetic programming
|
TW202344686A
(zh)
|
2015-10-30 |
2023-11-16 |
美國加利福尼亞大學董事會 |
從幹細胞產生t細胞之方法及使用該t細胞之免疫療法
|
LT3370733T
(lt)
|
2015-11-02 |
2021-10-25 |
Board Of Regents, The University Of Texas System |
Cd40 aktyvinimo ir imuninės kontrolės taškų blokados būdai
|
JP2018532810A
(ja)
|
2015-11-07 |
2018-11-08 |
マルチビア インコーポレイテッド |
がんの処置のための腫瘍抑制因子遺伝子治療および免疫チェックポイント治療を含む組成物
|
FI3373968T3
(fi)
|
2015-11-09 |
2024-07-17 |
Childrens Hospital Philadelphia |
Glypikaani 2 syövän merkkiaineena ja terapeuttisena kohteena
|
EP3419654B1
(de)
|
2016-02-22 |
2022-04-27 |
Evaxion Biotech A/S |
In impfstoffen gegen staphylococcus aureus nützliche proteine und nukleinsäuren
|
US20190177391A1
(en)
|
2016-03-31 |
2019-06-13 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
JP7099967B2
(ja)
|
2016-07-01 |
2022-07-12 |
リサーチ ディベロップメント ファウンデーション |
幹細胞由来移植片からの増殖性細胞の排除
|
US11414464B2
(en)
|
2016-07-22 |
2022-08-16 |
Evaxion Biotech A/S |
Chimeric proteins for inducing immunity towards infection with S. aureus
|
WO2018035429A1
(en)
|
2016-08-18 |
2018-02-22 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
|
CN115885615A
(zh)
|
2016-08-22 |
2023-04-04 |
拜欧卢米克有限公司 |
种子处理系统、装置和方法
|
CN109963590B
(zh)
|
2016-09-02 |
2024-03-15 |
加利福尼亚大学董事会 |
涉及白介素-6受体α结合单链可变片段的方法和组合物
|
EP3523422A1
(de)
|
2016-10-05 |
2019-08-14 |
FUJIFILM Cellular Dynamics, Inc. |
Erzeugung reifer linien aus induzierten pluripotenten stammzellen mit mecp2-unterbrechung
|
WO2018067836A1
(en)
|
2016-10-05 |
2018-04-12 |
Cellular Dynamics International, Inc. |
Methods for directed differentiation of pluripotent stem cells to hla homozygous immune cells
|
RU2646108C1
(ru)
*
|
2016-12-07 |
2018-03-01 |
Федеральное государственное бюджетное учреждение науки Институт биологии развития им. Н.К. Кольцова РАН |
Способ получения трансгенных растений пшеницы с использованием биобаллистики
|
JP2020510624A
(ja)
|
2016-12-12 |
2020-04-09 |
マルチビア インコーポレイテッド |
がんおよび感染性疾患の治療および予防のための、ウイルス遺伝子治療および免疫チェックポイント阻害剤を含む方法および組成物
|
WO2018127545A1
(en)
|
2017-01-05 |
2018-07-12 |
Evaxion Biotech Aps |
Vaccines targeting pseudomonas aeruginosa
|
US11180770B2
(en)
|
2017-03-07 |
2021-11-23 |
BASF Agricultural Solutions Seed US LLC |
HPPD variants and methods of use
|
US11371056B2
(en)
|
2017-03-07 |
2022-06-28 |
BASF Agricultural Solutions Seed US LLC |
HPPD variants and methods of use
|
BR112019021745A2
(pt)
|
2017-04-18 |
2020-05-05 |
Fujifilm Cellular Dynamics Inc |
células efetoras imunológicas antígeno-específicas
|
EP3621988A1
(de)
|
2017-05-09 |
2020-03-18 |
Bellicum Pharmaceuticals, Inc. |
Verfahren zur verstärkung oder änderung der signaltransduktion
|
WO2019038594A2
(en)
|
2017-08-21 |
2019-02-28 |
Biolumic Limited |
TRANSGENIC PLANTS WITH HIGH GROWTH AND HIGH RUSTICITY
|
EP3704250A1
(de)
|
2017-11-03 |
2020-09-09 |
InteRNA Technologies B.V. |
Mirna-molekül, äquivalent, antagomir oder quelle davon zur behandlung und/oder diagnose eines zustands und/oder einer erkrankung im zusammenhang mit neuronaler defizienz oder neuronaler (re)generation
|
WO2019099493A1
(en)
|
2017-11-14 |
2019-05-23 |
Henry Ford Health System |
Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
|
BR112020013715A2
(pt)
|
2018-01-05 |
2020-12-01 |
Ottawa Hospital Research Institute |
vetores de vaccinia modificados
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
AU2019322487B2
(en)
|
2018-03-19 |
2024-04-18 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and CD122/CD132 agonists for the treatment of cancer
|
CA3133899A1
(en)
|
2018-03-30 |
2019-10-03 |
University Of Geneva |
Micro rna expression constructs and uses thereof
|
US20220000932A1
(en)
|
2018-09-28 |
2022-01-06 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
WO2020083904A1
(en)
|
2018-10-22 |
2020-04-30 |
Evaxion Biotech Aps |
Vaccines targeting m. catharrhalis
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
US20220143168A1
(en)
|
2019-02-27 |
2022-05-12 |
Evaxion Biotech A/S |
Vaccines targeting H. influenzae
|
WO2020212756A2
(en)
|
2019-04-18 |
2020-10-22 |
Genkin Dmitry Dmitrievich |
Reprogramming of polymorphonuclear leukocytes
|
AU2020317009A1
(en)
|
2019-07-19 |
2022-02-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric antigen receptors containing Glypican 2 binding domains
|
CN115175680A
(zh)
|
2019-10-18 |
2022-10-11 |
加利福尼亚大学董事会 |
Plxdc激活剂及其用于治疗血管病症的用途
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
WO2021140123A1
(en)
|
2020-01-06 |
2021-07-15 |
Evaxion Biotech Aps |
Vaccines targeting neisseria gonorrhoeae
|
US20230242643A1
(en)
|
2020-05-27 |
2023-08-03 |
Antion Biosciences Sa |
Adapter molecules to re-direct car t cells to an antigen of interest
|
KR20230017876A
(ko)
|
2020-05-29 |
2023-02-06 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
망막 색소 상피 및 광수용체의 이중층 및 이의 용도
|
US20230201267A1
(en)
|
2020-05-29 |
2023-06-29 |
FUJIFILM Cellular Dynamics, Inc. |
Retinal pigmented epithelium and photoreceptor dual cell aggregates and methods of use thereof
|
WO2022053130A1
(en)
|
2020-09-09 |
2022-03-17 |
Sid Alex Group, S.R.O. |
Antago-mir-155 for treatment of v-src, c-src-tyrosine kinase-induced cancers
|
JP2024500847A
(ja)
|
2020-12-18 |
2024-01-10 |
センチュリー セラピューティクス,インコーポレイテッド |
適合可能な受容体特異性を有するキメラ抗原受容体システム
|
WO2022173767A1
(en)
|
2021-02-09 |
2022-08-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
WO2022175815A1
(en)
|
2021-02-19 |
2022-08-25 |
Pfizer Inc. |
Methods of protecting rna
|
WO2022216963A1
(en)
|
2021-04-08 |
2022-10-13 |
Janssen Biotech, Inc. |
Materials and methods for enhanced stem-cell like memory t cell engineering
|
WO2022235586A1
(en)
|
2021-05-03 |
2022-11-10 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature corneal endothelial cells
|
BR112023022181A2
(pt)
|
2021-05-07 |
2024-02-06 |
Astellas Inst For Regenerative Medicine |
Métodos de geração de hepatócitos maduros
|
EP4347796A1
(de)
|
2021-05-26 |
2024-04-10 |
Fujifilm Cellular Dynamics, Inc. |
Verfahren zur verhinderung des schnellen silencing von genen in pluripotenten stammzellen
|
WO2023280807A1
(en)
|
2021-07-05 |
2023-01-12 |
Evaxion Biotech A/S |
Vaccines targeting neisseria gonorrhoeae
|
WO2023081813A1
(en)
|
2021-11-05 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Zip cytokine receptors
|
WO2023081894A2
(en)
|
2021-11-08 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Pre-effector car-t cell gene signatures
|
WO2023089556A1
(en)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Reducing risk of antigen mimicry in immunogenic medicaments
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
WO2023178191A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
WO2023213393A1
(en)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
WO2023240182A1
(en)
|
2022-06-08 |
2023-12-14 |
St. Jude Children's Research Hospital, Inc. |
Disruption of kdm4a in t cells to enhance immunotherapy
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024006911A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Holdings America Corporation |
Ipsc-derived astrocytes and methods of use thereof
|
WO2024059787A1
(en)
|
2022-09-16 |
2024-03-21 |
St. Jude Children's Research Hospital, Inc. |
Disruption of asxl1 in t cells to enhance immunotherapy
|
WO2024130212A1
(en)
|
2022-12-16 |
2024-06-20 |
Turnstone Biologics Corp. |
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
|
WO2024186630A1
(en)
|
2023-03-03 |
2024-09-12 |
Henry Ford Health System |
Use of extracellular vesicles for the treatment of cancer
|